Is xamoterol safe in chronic airflow obstruction?
β Scribed by J. A. Roberts; V. F. Challenor; D. G. Waller
- Book ID
- 104700454
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 341 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
β¦ Synopsis
We have demonstrated in a group of 10 patients with CAO that treatment with xamoterol (200 mg b.i.d. for 7 days) did not alter lung function or respiratory symptoms. These results suggest that xamoterol can be used to treat mild heart failure in patients with CAO.
π SIMILAR VOLUMES
The hypothesis of an increased muscarinic receptor sensitivity in airway musculature of patients with chronic airflow obstruction (CAO) has been investigated by in vitro radioligand binding studies. The receptor binding profiles were determined in membrane homogenates of tracheal and main bronchial